Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Sells 3,404 Shares of Aflac Incorporated (NYSE:AFL)

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group lowered its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 24.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,649 shares of the financial services provider's stock after selling 3,404 shares during the quarter. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group's holdings in Aflac were worth $1,102,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Franklin Resources Inc. raised its stake in shares of Aflac by 75.2% in the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider's stock worth $88,533,000 after buying an additional 333,083 shares during the period. Aptus Capital Advisors LLC raised its stake in shares of Aflac by 79.7% in the third quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider's stock worth $3,058,000 after buying an additional 12,131 shares during the period. Transamerica Financial Advisors Inc. bought a new position in shares of Aflac in the third quarter worth about $979,000. Roxbury Financial LLC bought a new position in shares of Aflac in the fourth quarter worth about $948,000. Finally, FMR LLC raised its stake in shares of Aflac by 4.0% in the third quarter. FMR LLC now owns 1,202,104 shares of the financial services provider's stock worth $134,395,000 after buying an additional 45,745 shares during the period. Institutional investors own 67.44% of the company's stock.

Insider Transactions at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the firm's stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares of the company's stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is currently owned by company insiders.

Remove Ads

Aflac Price Performance

NYSE AFL traded up $2.34 during trading on Friday, hitting $107.44. 1,395,107 shares of the stock traded hands, compared to its average volume of 1,997,055. The company has a market capitalization of $58.72 billion, a P/E ratio of 11.19, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The firm has a 50-day simple moving average of $105.37 and a 200-day simple moving average of $107.69. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Analysts Set New Price Targets

AFL has been the topic of several recent research reports. JPMorgan Chase & Co. raised their price objective on Aflac from $90.00 to $94.00 and gave the stock a "neutral" rating in a research note on Tuesday, January 7th. BMO Capital Markets assumed coverage on Aflac in a research report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 target price for the company. Wells Fargo & Company cut their target price on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 19th. Barclays cut their target price on Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research report on Friday, February 7th. Finally, Evercore ISI cut their target price on Aflac from $104.00 to $102.00 and set an "underperform" rating for the company in a research report on Wednesday, December 4th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Aflac has a consensus rating of "Hold" and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.